Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Reexamination Certificate
2003-08-07
2008-08-05
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
C424S646000, C424S647000, C424S648000
Reexamination Certificate
active
07407673
ABSTRACT:
The present invention relates to radioactive magnetic fluids, process for preparing them and use thereof. Particularly, the present invention relates to the radioactive magnetic fluids for treatment or diagnosis of cancer, process for preparing them and use thereof.The radioactive magnetic fluids of the present invention include the component of Cu2+which radiates a β-ray and γ-ray. The β radiation can effectively kill the tumor cells. Since the γ radiation are easily imaged with γ-camera, the magnetic fluids can be gathered to the treatment site with the radiograph under external magnetic field. Therefore, the radioactive magnetic fluids of the present invention can be used for treatment of cancer with minimal side effects. Also, the tightly bonded decanoic acid and nonanoic acid layer of the present invention not only increase particle-particle repulsion but also take hydrophilicity, to disperse homogeneously and stably the magnetic nanoparticles in water. Also, carboxylic acid of the surfactant is exposed to outside, to prevent the magnetic nanoparticles from being oxidized by air.Therefore, the radioactive magnetic fluids can be used as therapeutic drug or diagnostic reagent for cancer.
REFERENCES:
patent: 4957481 (1990-09-01), Gatenby
patent: 5921244 (1999-07-01), Chen et al.
patent: 7138103 (2006-11-01), Goldenberg et al.
patent: 2004/0248856 (2004-12-01), Lanza et al.
patent: 2005/0085417 (2005-04-01), Wickstrom et al.
patent: 2006/0286379 (2006-12-01), Gao
Sincai et al in Journal of Magnetism and Magnetic Materials 225 (2001) 235-240□□.
Sieben et al in Journal of Magnetism and Magnetic Materials 225 (2001) 175-179.
Kuznetsov et al in Journal of Magnetism and Magnetic Materials 194 (1999) 22-30□□.
Kwon et al in Korean Journal of Materials Research vol. 12 (3) 2002 pp. 215 (English translation prepared by the USPTO).
Urs Hafeli et al., “Radiolabeling of Magnetic Particles with Rhenium-188 for Cancer Therapy”, Journal of Magnetism and Magnetic Materials, vol. 225, pp. 73-78 (2001).
Ch. Alexiou et al., “Magnetic Drug Targeting: Biodistribution and Dependency on Magnetic Field Strength”, Journal of Magnetism and Magnetic Materials, vol. 252, pp. 363-366 (2002).
Yuqiang Huang et al., “Preparation of nanometric CuχFe1−χOFe2O3for Treatment of Tumor”, Journal of Applied Physics, vol. 93, No. 10, pp. 8444-8446 (2003).
Huang Yuqiang
Kim Chong-Oh
Kim Jong-Hee
Park Sang-Im
Greenblum & Bernstein P.L.C.
Hartley Michael G.
Kim Chong-Oh
Silverman Eric E
LandOfFree
Radioactive magnetic fluids for treatment or diagnosis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioactive magnetic fluids for treatment or diagnosis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioactive magnetic fluids for treatment or diagnosis of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3996311